--- title: "Dragon and Tiger List | VITAL NEW MATERIAL (301319) rose by 13.77%, with the top 5 buyers purchasing a total of 29.33 billion yuan, and the top 5 sellers selling a total of 30.348 billion yuan. Reason for being listed: The cumulative deviation of the daily closing price increase during the period of severe abnormality reached 200%" type: "News" locale: "en" url: "https://longbridge.com/en/news/287050012.md" description: "VITAL NEW MATERIAL (301319) rose 13.77% on May 20, closing at 133.91 yuan, with a circulating market value of 12.525 billion yuan. The buying amount on the Dragon and Tiger List was 21.248 billion yuan, the selling amount was 30.348 billion yuan, and the net buying amount was 0 yuan. The total buying amount of the top 5 was 29.33 billion yuan, and the total selling amount of the top 5 was 30.348 billion yuan. The expected operating revenue for 2024 is 1.212 billion yuan, with a net profit of 89 million yuan and a net profit growth rate of -12.53%" datetime: "2026-05-20T10:46:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287050012.md) - [en](https://longbridge.com/en/news/287050012.md) - [zh-HK](https://longbridge.com/zh-HK/news/287050012.md) --- # Dragon and Tiger List | VITAL NEW MATERIAL (301319) rose by 13.77%, with the top 5 buyers purchasing a total of 29.33 billion yuan, and the top 5 sellers selling a total of 30.348 billion yuan. Reason for being listed: The cumulative deviation of the daily closing price increase during the period of severe abnormality reached 200% According to Tongbi Finance, on May 20, VITAL NEW MATERIAL (301319) appeared on the stock market's leaderboard. The reason for its listing: the stock's closing price deviation during a period of severe abnormality reached a cumulative increase of 200%. The buying amount on the leaderboard was CNY 21.248 billion, the selling amount was CNY 21.248 billion, and the net buying amount was CNY 0. The top 5 buying amounts totaled CNY 29.33 billion. Among them, the first buying position was an institutional investor, buying CNY 13.166 billion; the second position was an individual investor, buying CNY 8.082 billion; the third position was other individual investors, buying CNY 4.161 billion; the fourth position was small and medium investors, buying CNY 3.921 billion; the fifth position was Shenzhen Stock Connect investors, buying CNY 0. The top 5 selling amounts totaled CNY 30.348 billion. Among them, the first selling position was an institutional investor, selling CNY 12.149 billion; the second position was an individual investor, selling CNY 9.1 billion; the third position was other individual investors, selling CNY 5.039 billion; the fourth position was small and medium investors, selling CNY 4.061 billion; the fifth position was Shenzhen Stock Connect investors, selling CNY 0. As of the close on May 20, VITAL NEW MATERIAL (301319) rose by 13.77%, with a closing price of CNY 133.91, a circulating market value of CNY 12.525 billion, and a turnover rate of 12.35%. _Tongbi Finance Tips:_ _VITAL NEW MATERIAL (301319.SZ) is projected to have an operating income of CNY 1.212 billion in 2024, with a growth rate of 25.75%. The net profit attributable to the parent company is CNY 0.089 billion, with a net profit growth rate of -12.53%, and a return on equity of 7.89%._ _In the first half of 2025, the company's operating income is expected to be CNY 0.664 billion, with a growth rate of 26.74%. The net profit attributable to the parent company is CNY 0.042 billion, with a net profit growth rate of -14.76%._ _Currently, the company belongs to the information technology industry, with the main product types being specialized equipment and components. The 2024 report indicates that the main composition is microelectronic welding materials: 84.91%; microelectronic auxiliary welding materials: 13.18%; others: 1.91%._ ### Related Stocks - [301319.CN](https://longbridge.com/en/quote/301319.CN.md) ## Related News & Research - [4Sight expects FY earnings per share up 29.3%-40.1%](https://longbridge.com/en/news/287226173.md) - [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md) - [Should you buy Shopify stock on the dip?](https://longbridge.com/en/news/286656776.md) - [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md) - [Ganfeng Lithium starts small-scale production of 500 Wh/kg solid-state batteries](https://longbridge.com/en/news/287152551.md)